Self-administered intranasal medication to terminate supraventricular tachycardia. Campbell T, Kumar S. Lancet 2023;402:81-83.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Campbell T, Kumar S. Self-administered intranasal medication to terminate supraventricular tachycardia. Lancet 2023;402:81-83.
PMID: 37331367